No side-effects of single intranasal oxytocin administration in middle childhood.
Martine W F T VerheesJanne HoubenEva CeulemansMarian J Bakermans-KranenburgMarinus H van IJzendoornGuy BosmansPublished in: Psychopharmacology (2018)
In all, this study is the first randomized controlled trial to provide information on the safety of intranasal oxytocin administration in middle childhood. The current study suggests that single administration of intranasal oxytocin is likely safe in elementary school-aged children.